MAPT and tauopathy: These pathological changes occur in the absence of neurofibrillary tangle formation and without detectable cognitive impairment within the 12-week timeframe, highlighting the importance of tau accumulation thresholds, transgene duration, and animal age in modeling tauopathy-related cognitive decline.